These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 12171674)

  • 1. 'Skin popping' ulceration in an HIV patient. Successful treatment with antiretroviral drugs and stanozolol.
    Redondo P; Molano E; Lloret P; Bauza A
    Int J STD AIDS; 2002 Jul; 13(7):508-9. PubMed ID: 12171674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryofibrinogenaemia with a good response to stanozolol.
    Revenga F; Aguilar C; González R; Paricio JF; Sanz P; Santos I
    Clin Exp Dermatol; 2000 Nov; 25(8):621-3. PubMed ID: 11167976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous necrosis of the skin associated with cryofibrinogenemia, cryoglobulinemia, and homocystinuria.
    Williamson AE; Cone LA; Huard GS
    Ann Vasc Surg; 1996 Jul; 10(4):365-9. PubMed ID: 8879392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Popping': a cause of soft tissue sepsis in chronic drug abusers.
    Graham CA; McNaughton GW; Crawford R
    Eur J Emerg Med; 1999 Sep; 6(3):259-61. PubMed ID: 10622394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver enzymes and lipid levels in patients with lipodermatosclerosis and venous ulcers treated with a prototypic anabolic steroid (stanozolol): a prospective, randomized, double-blinded, placebo-controlled trial.
    Carson P; Hong CJ; Otero-Vinas M; Arsenault EF; Falanga V
    Int J Low Extrem Wounds; 2015 Mar; 14(1):11-8. PubMed ID: 25652757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aquagenic urticaria and human immunodeficiency virus infection: treatment with stanozolol.
    Fearfield LA; Gazzard B; Bunker CB
    Br J Dermatol; 1997 Oct; 137(4):620-2. PubMed ID: 9390343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of collagen synthesis by the anabolic steroid stanozolol.
    Falanga V; Greenberg AS; Zhou L; Ochoa SM; Roberts AB; Falabella A; Yamaguchi Y
    J Invest Dermatol; 1998 Dec; 111(6):1193-7. PubMed ID: 9856839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Building your body to survive: the use of anabolic steroids for HIV therapy.
    Vergel N
    Posit Aware; 1998; 9(2):37-41. PubMed ID: 11365225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stanozolol causes rapid pain relief and healing of cutaneous ulcers caused by cryofibrinogenemia.
    Kirsner RS; Eaglstein WH; Katz MH; Kerdel FA; Falanga V
    J Am Acad Dermatol; 1993 Jan; 28(1):71-4. PubMed ID: 8425973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case report. Severe cutaneous ulceration secondary to cytomegalovirus inclusion disease during successful immune reconstitution with HAART.
    Qazi NA; Morlese JF; Walsh JC; Bunker CB; Francis N; Nelson MR
    AIDS Read; 2002 Oct; 12(10):452-4, 456-7. PubMed ID: 12408103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Universal access to HIV/AIDS treatment for injecting drug users: keeping the promise.
    Ball AL
    Int J Drug Policy; 2007 Aug; 18(4):241-5. PubMed ID: 17689371
    [No Abstract]   [Full Text] [Related]  

  • 12. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.
    Wang C; Vlahov D; Galai N; Bareta J; Strathdee SA; Nelson KE; Sterling TR
    J Infect Dis; 2004 Sep; 190(6):1046-54. PubMed ID: 15319852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Access to highly active antiretroviral therapy (HAART) for injecting drug users in the WHO European Region 2002-2004.
    Donoghoe MC; Bollerup AR; Lazarus JV; Nielsen S; Matic S
    Int J Drug Policy; 2007 Aug; 18(4):271-80. PubMed ID: 17689375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conflicts in the treatment of chronic ulcers in drug addicts--case series and discussion.
    Williams AM; Southern SJ
    Br J Plast Surg; 2005 Oct; 58(7):997-9. PubMed ID: 16040018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Controlled clinical research on 2 anabolic agents with prolonged action].
    Porsio A; Borgia M
    Minerva Med; 1968 Feb; 59(15):824-8. PubMed ID: 5642246
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiretroviral HIV treatment and care for injecting drug users: an evidence-based overview.
    Lert F; Kazatchkine MD
    Int J Drug Policy; 2007 Aug; 18(4):255-61. PubMed ID: 17689373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Controlled clinical trials of the use of a new anabolic agent in a Sanatorium].
    Porsio A; Borgia M
    Clin Ter; 1966 Jun; 37(6):502-18. PubMed ID: 4865920
    [No Abstract]   [Full Text] [Related]  

  • 18. Conservative management of canine tracheal collapse with stanozolol: a double blinded, placebo control clinical trial.
    Adamama-Moraitou KK; Pardali D; Athanasiou LV; Prassinos NN; Kritsepi M; Rallis TS
    Int J Immunopathol Pharmacol; 2011; 24(1):111-8. PubMed ID: 21496393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alcohol use and incarceration adversely affect HIV-1 RNA suppression among injection drug users starting antiretroviral therapy.
    Palepu A; Tyndall MW; Li K; Yip B; O'Shaughnessy MV; Schechter MT; Montaner JS; Hogg RS
    J Urban Health; 2003 Dec; 80(4):667-75. PubMed ID: 14709714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staging for antiretroviral therapy among HIV-infected drug users.
    Wood E; Hogg RS; Bonner S; Kerr T; Li K; Palepu A; Guillemi S; Schechter MT; Montaner JS
    JAMA; 2004 Sep; 292(10):1175-7. PubMed ID: 15353528
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.